Research location

Red Deer

Alberta, Canada

Published trials73

Site observations74

Linked trials published73

Page1 / 2

Research activity in Red Deer

Alberta, Canada

CureCurrent currently publishes aggregate city-level research activity for this location: 73 trials and 74 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Red Deer

73 linked trials · page 1 of 2

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes MedicationsNCT07797335 · 2026-08-24 · 1 site observation

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseNCT07064473 · 2025-07-22 · 1 site observation

A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or ObesityNCT07861100 · 2026-10-26 · 1 site observation

NOT_YET_RECRUITING

A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)NCT06077864 · 2023-11-20 · 1 site observation

A Research Study to Compare Two Semaglutide Medicines in People With Type 2 DiabetesNCT05478252 · 2022-08-03 · 1 site observation

A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate HypertensionNCT04936035 · 2021-07-07 · 1 site observation

A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney DiseaseNCT04750577 · 2021-04-27 · 1 site observation

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)NCT04795531 · 2021-03-24 · 1 site observation

A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin BeforeNCT04760626 · 2021-03-01 · 1 site observation

A Phase 2b Diabetic Kidney Disease StudyNCT04170543 · 2019-11-18 · 1 site observation

A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney DiseaseNCT03819153 · 2019-06-17 · 1 site observation

Hockey Fans in Training (Hockey FIT): Improving Men's Health Through the Power of SportNCT03636282 · 2018-11-13 · 1 site observation

Patient Reported Outcomes in Adults With Severe Eosinophilic Asthma on Benralizumab.NCT03833141 · 2018-11-12 · 1 site observation

A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 DiabetesNCT03495102 · 2018-04-05 · 1 site observation

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04NCT03383146 · 2018-02-01 · 1 site observation

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03NCT03420781 · 2018-01-24 · 1 site observation

A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 DiabetesNCT03235050 · 2017-08-02 · 1 site observation

Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)NCT03071692 · 2017-03-23 · 1 site observation

Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on MetforminNCT03060980 · 2017-03-03 · 1 site observation

COPD Discharge Bundle Delivered Alone or Enhanced Through a Care CoordinatorNCT03358771 · 2017-03-01 · 1 site observation

INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart FailureNCT02787044 · 2016-08-01 · 1 site observation

Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)NCT02580591 · 2015-12-22 · 1 site observation

Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) PatientsNCT02666430 · 2015-12-01 · 1 site observation

Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)NCT02414958 · 2015-06-30 · 1 site observation

A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 DiabetesNCT02413398 · 2015-06-15 · 1 site observation

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)NCT02227862 · 2014-06-01 · 1 site observation

SODIUM-HF: Study of Dietary Intervention Under 100 MMOL in Heart FailureNCT02012179 · 2014-03-24 · 1 site observation

A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusNCT01991795 · 2014-02-10 · 1 site observation

Safety, Tolerability and Efficacy of ISIS-GCCRRx in Type 2 DiabetesNCT01968265 · 2013-10-01 · 1 site observation

Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)NCT01897532 · 2013-07-10 · 1 site observation

Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 DiabetesNCT01834274 · 2013-06-01 · 1 site observation

Self-Management and Educational Support in Extremely Obese Patients Awaiting Bariatric CareNCT01860131 · 2013-03-01 · 1 site observation

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 DiabetesNCT01778049 · 2013-01-01 · 1 site observation

A Study in Participants With Type I Diabetes MellitusNCT01454284 · 2012-01-01 · 1 site observation

Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 DiabetesNCT01512979 · 2012-01-01 · 1 site observation

Facilitating Physical Activity Behavior and Health Outcomes in Breast Cancer Patients Receiving ChemotherapyNCT01053468 · 2010-08-01 · 1 site observation

The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)NCT01137812 · 2010-07-01 · 1 site observation

A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 DiabetesNCT01149421 · 2010-06-01 · 1 site observation

Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes MedicationsNCT01107886 · 2010-05-01 · 1 site observation

A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes MellitusNCT01042769 · 2010-02-01 · 1 site observation

Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg BidNCT00915772 · 2009-06-01 · 1 site observation

Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial DesignNCT00798161 · 2008-12-01 · 1 site observation

Canadian Study of Trandolapril on Blood Pressure in Hypertensive PatientsNCT01078584 · 2008-12-01 · 2 site observations

One-Year Trial Of Oral Ziprasidone In Patients With Metabolic SyndromeNCT00748566 · 2008-12-01 · 1 site observation

Follow-Up Study for ExuberaNCT00734591 · 2008-08-01 · 1 site observation

A Diabetes Study to Treat A Population Previously Not at TargetNCT00747149 · 2008-05-01 · 1 site observation

Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With SchizophreniaNCT00640601 · 2008-03-01 · 1 site observation

Proof of Concept Study of Cognitive Improvement in Patients With SchizophreniaNCT00528905 · 2007-08-01 · 1 site observation

Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes MellitusNCT01101945 · 2007-07-01 · 1 site observation

A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart FailureNCT00475852 · 2007-05-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.